GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

July 26, 2019

Study Completion Date

July 26, 2019

Conditions

Prader-Willi Syndrome

Interventions

DRUG

Growth hormone

12 months on Growth hormone, initial dose 0,2 mg per day, then adjusted by insulin like growth factor (IGF-1) level

DRUG

Placebo

2 months on placebo, sodium chloride 0,9% injections

Trial Locations (1)

Parc Taulí Hospital Universitari, Sabadell